Cantor Fitzgerald Starts Thermo Fisher Scientific (TMO) at Buy; Leading the Way for Life Science Tools
Tweet
Share
E-mailGet Alerts TMO Hot Sheet
Price: $588.29 -1.28%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cantor Fitzgerald initiates coverage on Thermo Fisher Scientific (NYSE: TMO) with a Buy. PT $57.00.
Cantor analyst said, "As the largest provider of life science tools, TMO has a strong track record of delivering mid-single-digit organic revenue growth and double-digit EPS growth. Despite little change in fundamentals over the last year, shares are trading near trough multiples, compared to the peer group and S&P 500. As such, we think TMO's current valuation offers an attractive entry point for investors. Consistent financial performance despite the size. We believe TMO is well-positioned to continue to achieve its long-term growth target of low- to mid-teens EPS growth, driven by efficient R&D investments, emerging markets, disciplined OM improvement, and strong FCF generation allowing aggressive share
repurchases."
For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.
Shares of Thermo Fisher Scientific closed at $45.95 yesterday.
Cantor analyst said, "As the largest provider of life science tools, TMO has a strong track record of delivering mid-single-digit organic revenue growth and double-digit EPS growth. Despite little change in fundamentals over the last year, shares are trading near trough multiples, compared to the peer group and S&P 500. As such, we think TMO's current valuation offers an attractive entry point for investors. Consistent financial performance despite the size. We believe TMO is well-positioned to continue to achieve its long-term growth target of low- to mid-teens EPS growth, driven by efficient R&D investments, emerging markets, disciplined OM improvement, and strong FCF generation allowing aggressive share
repurchases."
For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.
Shares of Thermo Fisher Scientific closed at $45.95 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Downgrades Better Home & Finance Holding (BETR) to Neutral
- UBS Starts Schrodinger (SDGR) at Neutral
- JPMorgan Resumes SanDisk (SNDK) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cantor Fitzgerald, Standard & Poor'sSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
